Skip to main content
. 2022 Dec 1;13:1032747. doi: 10.3389/fimmu.2022.1032747

Figure 8.

Figure 8

Selected outcomes reported by influential studies. a The POSEIDON trial did not report the ORR. b The POPLAR trial did not report the PFS. PFS, progression-free survival. OS, overall survival. ORR, objectively response rate. TMB-H, high tumor mutational burden.